Latest CATIE results: Atypicals no better than Trilafon for improving cognition
The Carlat Psychiatry Report, Volume 5, Number 7, July 2007
https://www.thecarlatreport.com/newsletter-issue/tcprv5n7/
Issue Links: Learning Objectives | Editorial Information
Topics: Antipsychotics
Jesse H. Wright, MD
One of the final major questions that the NIMH-funded CATIE trials promised to answer was whether atypical antipsychotics are better at improving cognition in schizophrenia than conventional agents, as some smaller studies implied.
You can't view details of this content, please login or buy subscription here
Jesse H. Wright, MD
Professor and Chief of Adult Psychiatry, University of Louisville School of Medicine, Co-author, Learning Cognitive Behavior Therapy: An Illustrated Guide
Dr. Wright has disclosed that he receives royalities from books he has written about cognitive behavioral therapy.